SchneeweissSSetoguchiSBrookhartA, et al.Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ. 2007;176(5):627–632.
4.
LubartESegalRYearovoiA, et al.QT interval disturbances in hospitalized elderly patients. Isr Med Assoc J. 2009;11(3):147–150.
5.
ViewegWVHasnainMHancoxJC, et al.Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports. Psychopharmacology (Berl). 2013;228(4):515–524.
6.
HasnainMViewegWVHowlandRH, et al.Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports. Ther Adv Psychopharmacol.2014;4(3):130–138.
7.
WuCSTsaiYTTsaiHJ. Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study. J Am Heart Assoc. 2015;4(2):e001568.
8.
PotkinSGPreskornSHochfeldM, et al.A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone. J Clin Psychopharmacol. 2013;33(1):3–10.
9.
HarriganEPMiceliJJAnzianoR, et al.A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004;24(1):62–69.
10.
TsetskhladzeEKhintibidzeI. QTc tendency in pacemaker dependent patients—prognostic meaning of long QTc during 5 year follow up. Georgian Med News. 2016;(253):56–60.
11.
XiongGLPinkhasovAMangalJP, et al.QTc monitoring in adults with medical and psychiatric comorbidities: expert consensus from the Association of Medicine and Psychiatry. J Psychosom Res. 2020;135:110138.
12.
Wenzel-SeifertKWittmannMHaenE. QTc prolongation by psychotropic drugs and the risk of torsade de pointes. Dtsch Arztebl Int. 2011;108(41):687–693.
